

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 4.89177660 |
| 2 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.86209128 |
| 3 | response to peptidoglycan (GO:0032494) | 4.51712952 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.35462333 |
| 5 | B cell mediated immunity (GO:0019724) | 3.96515558 |
| 6 | NIK/NF-kappaB signaling (GO:0038061) | 3.86761357 |
| 7 | actin nucleation (GO:0045010) | 3.84507972 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.83891110 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.83036597 |
| 10 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.80735726 |
| 11 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.79446136 |
| 12 | negative regulation of phagocytosis (GO:0050765) | 3.68340292 |
| 13 | GDP-mannose metabolic process (GO:0019673) | 3.59382222 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.59339173 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.56060565 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.47966388 |
| 17 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45748170 |
| 18 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.43544723 |
| 19 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.43399051 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.40137796 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.40137796 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.39921451 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.35677501 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.35677501 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.35677501 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.35677501 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.35677501 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 3.35677501 |
| 29 | respiratory burst (GO:0045730) | 3.35533871 |
| 30 | sequestering of actin monomers (GO:0042989) | 3.35144802 |
| 31 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.32799547 |
| 32 | detection of bacterium (GO:0016045) | 3.32369129 |
| 33 | T-helper 1 type immune response (GO:0042088) | 3.31335053 |
| 34 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.30163606 |
| 35 | type I interferon signaling pathway (GO:0060337) | 3.29462882 |
| 36 | cellular response to type I interferon (GO:0071357) | 3.29462882 |
| 37 | positive regulation of macrophage cytokine production (GO:0060907) | 3.28810268 |
| 38 | protein maturation by protein folding (GO:0022417) | 3.26327373 |
| 39 | regulation of B cell apoptotic process (GO:0002902) | 3.21496102 |
| 40 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.21419985 |
| 41 | response to type I interferon (GO:0034340) | 3.18681627 |
| 42 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.12379475 |
| 43 | detection of other organism (GO:0098543) | 3.11943051 |
| 44 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.11159891 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 3.11137135 |
| 46 | negative regulation of B cell apoptotic process (GO:0002903) | 3.11005855 |
| 47 | regulation of antigen processing and presentation (GO:0002577) | 3.07844158 |
| 48 | regulation of hexokinase activity (GO:1903299) | 3.03457382 |
| 49 | regulation of glucokinase activity (GO:0033131) | 3.03457382 |
| 50 | base-excision repair, AP site formation (GO:0006285) | 3.00526081 |
| 51 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.98963762 |
| 52 | negative regulation of type 2 immune response (GO:0002829) | 2.94696739 |
| 53 | response to interferon-beta (GO:0035456) | 2.91977424 |
| 54 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.91900487 |
| 55 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.90208182 |
| 56 | detection of external biotic stimulus (GO:0098581) | 2.89441625 |
| 57 | deoxyribose phosphate catabolic process (GO:0046386) | 2.89356844 |
| 58 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88661418 |
| 59 | regulation of macrophage cytokine production (GO:0010935) | 2.87007733 |
| 60 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.85328958 |
| 61 | neutrophil activation (GO:0042119) | 2.82130470 |
| 62 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.81515444 |
| 63 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.80069584 |
| 64 | galactose catabolic process (GO:0019388) | 2.79158584 |
| 65 | negative thymic T cell selection (GO:0045060) | 2.78744941 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.77002506 |
| 67 | B cell receptor signaling pathway (GO:0050853) | 2.74911993 |
| 68 | positive regulation of interferon-alpha production (GO:0032727) | 2.74729794 |
| 69 | positive regulation of protein homooligomerization (GO:0032464) | 2.74643834 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.73499219 |
| 71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.72408877 |
| 72 | regulation of memory T cell differentiation (GO:0043380) | 2.70412803 |
| 73 | detection of molecule of bacterial origin (GO:0032490) | 2.70237335 |
| 74 | deoxyribonucleotide catabolic process (GO:0009264) | 2.66999116 |
| 75 | cellular response to interferon-beta (GO:0035458) | 2.66731458 |
| 76 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.65531277 |
| 77 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.65306444 |
| 78 | positive thymic T cell selection (GO:0045059) | 2.65025015 |
| 79 | regulation of interferon-alpha production (GO:0032647) | 2.60013785 |
| 80 | granulocyte activation (GO:0036230) | 2.58930236 |
| 81 | positive regulation of cytokine production involved in immune response (GO:0002720) | 2.58476584 |
| 82 | cellular response to interferon-gamma (GO:0071346) | 2.57599867 |
| 83 | response to muramyl dipeptide (GO:0032495) | 2.57546733 |
| 84 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.54565502 |
| 85 | negative T cell selection (GO:0043383) | 2.54175199 |
| 86 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.53448552 |
| 87 | positive regulation of interferon-gamma production (GO:0032729) | 2.52818602 |
| 88 | regulation of mast cell degranulation (GO:0043304) | 2.51124070 |
| 89 | negative regulation of bone resorption (GO:0045779) | 2.49121290 |
| 90 | detection of biotic stimulus (GO:0009595) | 2.48837964 |
| 91 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.48393624 |
| 92 | negative regulation of chemokine production (GO:0032682) | 2.47260064 |
| 93 | cobalamin metabolic process (GO:0009235) | 2.47169693 |
| 94 | leukocyte aggregation (GO:0070486) | 2.45241465 |
| 95 | regulation of interleukin-12 production (GO:0032655) | 2.41343140 |
| 96 | positive regulation of interleukin-17 production (GO:0032740) | 2.41302244 |
| 97 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.39960854 |
| 98 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.39893337 |
| 99 | regulation of mitochondrial translation (GO:0070129) | 2.39796358 |
| 100 | negative regulation of innate immune response (GO:0045824) | 2.38645440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.67723920 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.42467875 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.67903148 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.63681387 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60335443 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.59171076 |
| 7 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.57913901 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.55625951 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49645823 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.44792768 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.21406087 |
| 12 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.19583890 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.19379596 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.17152396 |
| 15 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09903072 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.09596443 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06158349 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.02789337 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01640651 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98914973 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.93673511 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.91459173 |
| 23 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.84170724 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.79776541 |
| 25 | MAF_26560356_Chip-Seq_TH2_Human | 1.79125461 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77791510 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77531648 |
| 28 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.76876529 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76230314 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74996304 |
| 31 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.74375536 |
| 32 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.73299172 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70989141 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70225238 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68126838 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.64499891 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62092002 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61995575 |
| 39 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.61783728 |
| 40 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.60426470 |
| 41 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.57312926 |
| 42 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.54392680 |
| 43 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.52567207 |
| 44 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.51239036 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49323234 |
| 46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.46762011 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.46393985 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44616433 |
| 49 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.39519257 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.37600484 |
| 51 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.36365390 |
| 52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.35909959 |
| 53 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34481526 |
| 54 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.34441918 |
| 55 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.34230202 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.32257158 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31656835 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.30947132 |
| 59 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30152371 |
| 60 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.29987150 |
| 61 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.28099777 |
| 62 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.27866166 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27724272 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27403440 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26050237 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25840170 |
| 67 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.25536333 |
| 68 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24884606 |
| 69 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.22688177 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22132104 |
| 71 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.21879895 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21741027 |
| 73 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.21502842 |
| 74 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.20945871 |
| 75 | MYB_26560356_Chip-Seq_TH2_Human | 1.20872718 |
| 76 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.20401475 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 1.19740667 |
| 78 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.19281985 |
| 79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18436020 |
| 80 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.18201497 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17768528 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17109142 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16655273 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15320853 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15281084 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15059318 |
| 87 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.13604348 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12841612 |
| 89 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12761747 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12668371 |
| 91 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.12204697 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.10548397 |
| 93 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.10534511 |
| 94 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09649851 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.09402954 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07940131 |
| 97 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07669767 |
| 98 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.07586185 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07513998 |
| 100 | P300_27268052_Chip-Seq_Bcells_Human | 1.06315665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.70295882 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.31425990 |
| 3 | MP0003436_decreased_susceptibility_to | 3.12939210 |
| 4 | MP0005451_abnormal_body_composition | 2.85880665 |
| 5 | MP0000685_abnormal_immune_system | 2.81207252 |
| 6 | MP0001790_abnormal_immune_system | 2.77986041 |
| 7 | MP0005387_immune_system_phenotype | 2.77986041 |
| 8 | MP0005671_abnormal_response_to | 2.66210321 |
| 9 | MP0008260_abnormal_autophagy | 2.57242058 |
| 10 | MP0001800_abnormal_humoral_immune | 2.52576118 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.47476581 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.47173236 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.46266915 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.28498094 |
| 15 | MP0009785_altered_susceptibility_to | 2.24149904 |
| 16 | MP0005025_abnormal_response_to | 2.22806073 |
| 17 | MP0001905_abnormal_dopamine_level | 2.21529730 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.20428127 |
| 19 | MP0002723_abnormal_immune_serum | 2.19020115 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 2.17789423 |
| 21 | MP0003183_abnormal_peptide_metabolism | 2.14278107 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 2.12355133 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.06685585 |
| 24 | MP0003724_increased_susceptibility_to | 2.05232345 |
| 25 | MP0001819_abnormal_immune_cell | 2.05063478 |
| 26 | MP0002822_catalepsy | 1.97812485 |
| 27 | MP0002419_abnormal_innate_immunity | 1.94767072 |
| 28 | MP0009278_abnormal_bone_marrow | 1.86221958 |
| 29 | MP0002398_abnormal_bone_marrow | 1.81872324 |
| 30 | MP0005083_abnormal_biliary_tract | 1.80749499 |
| 31 | MP0002277_abnormal_respiratory_mucosa | 1.80058772 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.73541048 |
| 33 | MP0006054_spinal_hemorrhage | 1.67381501 |
| 34 | MP0000716_abnormal_immune_system | 1.63101614 |
| 35 | MP0003011_delayed_dark_adaptation | 1.61210324 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.60458488 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.60436178 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.53432559 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.52320962 |
| 40 | MP0009764_decreased_sensitivity_to | 1.47553687 |
| 41 | MP0002722_abnormal_immune_system | 1.46255224 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.44383827 |
| 43 | MP0003866_abnormal_defecation | 1.44058093 |
| 44 | MP0002429_abnormal_blood_cell | 1.40549331 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.39801221 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.37427901 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.37427901 |
| 48 | MP0008469_abnormal_protein_level | 1.32287430 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.32047761 |
| 50 | MP0006035_abnormal_mitochondrial_morpho | 1.31987376 |
| 51 | MP0002102_abnormal_ear_morphology | 1.28317367 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.24526869 |
| 53 | MP0001542_abnormal_bone_strength | 1.24103553 |
| 54 | MP0000490_abnormal_crypts_of | 1.22646223 |
| 55 | MP0004510_myositis | 1.22421674 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.20845786 |
| 57 | MP0006082_CNS_inflammation | 1.19985406 |
| 58 | MP0000858_altered_metastatic_potential | 1.17641959 |
| 59 | MP0004947_skin_inflammation | 1.17342413 |
| 60 | MP0001529_abnormal_vocalization | 1.16202201 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.15411873 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.14104116 |
| 63 | MP0002132_abnormal_respiratory_system | 1.13381375 |
| 64 | MP0005310_abnormal_salivary_gland | 1.13338438 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.12613082 |
| 66 | MP0009840_abnormal_foam_cell | 1.12080179 |
| 67 | MP0000343_altered_response_to | 1.11923263 |
| 68 | MP0002405_respiratory_system_inflammati | 1.07690258 |
| 69 | MP0003075_altered_response_to | 1.05557250 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.00332017 |
| 71 | MP0000703_abnormal_thymus_morphology | 0.98178414 |
| 72 | MP0001727_abnormal_embryo_implantation | 0.95681883 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 0.93926332 |
| 74 | MP0003091_abnormal_cell_migration | 0.93718146 |
| 75 | MP0001756_abnormal_urination | 0.93431984 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 0.91297992 |
| 77 | MP0004883_abnormal_blood_vessel | 0.90820664 |
| 78 | MP0002693_abnormal_pancreas_physiology | 0.87928838 |
| 79 | MP0000358_abnormal_cell_content/ | 0.87417667 |
| 80 | MP0005166_decreased_susceptibility_to | 0.86835342 |
| 81 | MP0001348_abnormal_lacrimal_gland | 0.83555636 |
| 82 | MP0001663_abnormal_digestive_system | 0.82584884 |
| 83 | MP0005085_abnormal_gallbladder_physiolo | 0.78989752 |
| 84 | MP0002163_abnormal_gland_morphology | 0.76619438 |
| 85 | MP0003279_aneurysm | 0.75449238 |
| 86 | MP0009763_increased_sensitivity_to | 0.73836646 |
| 87 | MP0005390_skeleton_phenotype | 0.73193666 |
| 88 | MP0002735_abnormal_chemical_nociception | 0.72514498 |
| 89 | MP0000538_abnormal_urinary_bladder | 0.71773215 |
| 90 | MP0000371_diluted_coat_color | 0.70519077 |
| 91 | MP0002019_abnormal_tumor_incidence | 0.69784239 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.69399968 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.67905109 |
| 94 | MP0008874_decreased_physiological_sensi | 0.67227926 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.66057927 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.65983038 |
| 97 | MP0005501_abnormal_skin_physiology | 0.65753900 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65618823 |
| 99 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65358251 |
| 100 | MP0002089_abnormal_postnatal_growth/wei | 0.63421333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal infarctions (HP:0005244) | 3.93091927 |
| 2 | Petechiae (HP:0000967) | 3.85746252 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.79044679 |
| 4 | Abnormality of macrophages (HP:0004311) | 3.73497428 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.66727270 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.55332354 |
| 7 | Generalized aminoaciduria (HP:0002909) | 3.24862657 |
| 8 | Hemorrhage of the eye (HP:0011885) | 3.19801980 |
| 9 | Agammaglobulinemia (HP:0004432) | 3.19762859 |
| 10 | Increased IgM level (HP:0003496) | 3.19496680 |
| 11 | Meningitis (HP:0001287) | 3.09714861 |
| 12 | Testicular atrophy (HP:0000029) | 3.09152030 |
| 13 | Vasculitis (HP:0002633) | 3.06492399 |
| 14 | Exertional dyspnea (HP:0002875) | 3.04829160 |
| 15 | Obstructive lung disease (HP:0006536) | 3.02220620 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02220620 |
| 17 | Abnormal gallbladder physiology (HP:0012438) | 2.95844826 |
| 18 | Cholecystitis (HP:0001082) | 2.95844826 |
| 19 | Hepatic necrosis (HP:0002605) | 2.89743663 |
| 20 | Chest pain (HP:0100749) | 2.82865179 |
| 21 | Eczematoid dermatitis (HP:0000976) | 2.81911445 |
| 22 | Cellulitis (HP:0100658) | 2.80093001 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 2.79770366 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 2.78232968 |
| 25 | Increased hepatocellular lipid droplets (HP:0006565) | 2.77435209 |
| 26 | Epistaxis (HP:0000421) | 2.77175694 |
| 27 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.76969463 |
| 28 | Prolonged neonatal jaundice (HP:0006579) | 2.73280588 |
| 29 | Dry hair (HP:0011359) | 2.68659276 |
| 30 | Increased intramyocellular lipid droplets (HP:0012240) | 2.68411161 |
| 31 | Gastrointestinal inflammation (HP:0004386) | 2.64002649 |
| 32 | Inflammation of the large intestine (HP:0002037) | 2.63951258 |
| 33 | Lipid accumulation in hepatocytes (HP:0006561) | 2.61260603 |
| 34 | Gingival bleeding (HP:0000225) | 2.58379061 |
| 35 | Rough bone trabeculation (HP:0100670) | 2.57103223 |
| 36 | Recurrent skin infections (HP:0001581) | 2.56523173 |
| 37 | Recurrent bronchitis (HP:0002837) | 2.54871074 |
| 38 | Myositis (HP:0100614) | 2.54578961 |
| 39 | Hypertensive crisis (HP:0100735) | 2.54209597 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.52594964 |
| 41 | Urticaria (HP:0001025) | 2.51944165 |
| 42 | Papilloma (HP:0012740) | 2.51669149 |
| 43 | Verrucae (HP:0200043) | 2.51669149 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.41839842 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.41839842 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.41839842 |
| 47 | Abnormal pupillary function (HP:0007686) | 2.41718931 |
| 48 | Acute hepatic failure (HP:0006554) | 2.41596605 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.41087334 |
| 50 | Hepatocellular necrosis (HP:0001404) | 2.36125143 |
| 51 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.35164707 |
| 52 | Abnormal trabecular bone morphology (HP:0100671) | 2.30950521 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.29782558 |
| 54 | Gastrointestinal stroma tumor (HP:0100723) | 2.22101248 |
| 55 | Purpura (HP:0000979) | 2.20008875 |
| 56 | Amaurosis fugax (HP:0100576) | 2.18567493 |
| 57 | Stomatitis (HP:0010280) | 2.16681129 |
| 58 | IgG deficiency (HP:0004315) | 2.16510216 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.14413883 |
| 60 | Chronic sinusitis (HP:0011109) | 2.14074345 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.12261577 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.12261577 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11520459 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11520459 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11520459 |
| 66 | Lymphopenia (HP:0001888) | 2.10986906 |
| 67 | Hypothermia (HP:0002045) | 2.09644438 |
| 68 | Peritonitis (HP:0002586) | 2.09488772 |
| 69 | Recurrent sinusitis (HP:0011108) | 2.06233533 |
| 70 | Poikiloderma (HP:0001029) | 2.05530524 |
| 71 | Recurrent fungal infections (HP:0002841) | 2.05283173 |
| 72 | Spontaneous hematomas (HP:0007420) | 2.04987501 |
| 73 | Glycosuria (HP:0003076) | 2.04664917 |
| 74 | Abnormality of urine glucose concentration (HP:0011016) | 2.04664917 |
| 75 | Squamous cell carcinoma (HP:0002860) | 2.03055553 |
| 76 | Mitochondrial inheritance (HP:0001427) | 2.02233214 |
| 77 | Encephalitis (HP:0002383) | 2.00412036 |
| 78 | Increased serum ferritin (HP:0003281) | 1.99205552 |
| 79 | Nausea (HP:0002018) | 1.96699629 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.96373478 |
| 81 | Zonular cataract (HP:0010920) | 1.96371303 |
| 82 | Polyphagia (HP:0002591) | 1.96306921 |
| 83 | Mucopolysacchariduria (HP:0008155) | 1.95830409 |
| 84 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95830409 |
| 85 | Recurrent pneumonia (HP:0006532) | 1.94990959 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 1.94267401 |
| 87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94267401 |
| 88 | Recurrent lower respiratory tract infections (HP:0002783) | 1.91299910 |
| 89 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.90919359 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90479019 |
| 91 | Renal cortical cysts (HP:0000803) | 1.89652035 |
| 92 | Facial diplegia (HP:0001349) | 1.87657340 |
| 93 | Sepsis (HP:0100806) | 1.87004762 |
| 94 | Restrictive lung disease (HP:0002091) | 1.86052991 |
| 95 | Basal cell carcinoma (HP:0002671) | 1.85810003 |
| 96 | Skin rash (HP:0000988) | 1.85524037 |
| 97 | Colitis (HP:0002583) | 1.85437393 |
| 98 | Orchitis (HP:0100796) | 1.84806629 |
| 99 | Pulmonary fibrosis (HP:0002206) | 1.84307689 |
| 100 | Cerebral ischemia (HP:0002637) | 1.83611193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 3.24323701 |
| 2 | BLK | 2.99048229 |
| 3 | BCKDK | 2.91958483 |
| 4 | TLK1 | 2.89378371 |
| 5 | RIPK4 | 2.87113717 |
| 6 | VRK2 | 2.84435856 |
| 7 | ZAK | 2.56524752 |
| 8 | TESK1 | 2.51727648 |
| 9 | MAP4K1 | 2.39634433 |
| 10 | TBK1 | 2.37320234 |
| 11 | GRK6 | 2.34041138 |
| 12 | VRK1 | 2.25600045 |
| 13 | ERN1 | 2.15909231 |
| 14 | IRAK4 | 2.09318972 |
| 15 | MAP2K7 | 2.07638285 |
| 16 | KDR | 1.91376201 |
| 17 | ARAF | 1.85842056 |
| 18 | PRPF4B | 1.77131056 |
| 19 | TAOK1 | 1.74810667 |
| 20 | TAOK2 | 1.72722287 |
| 21 | TYK2 | 1.68862227 |
| 22 | MAP2K3 | 1.66022773 |
| 23 | SIK3 | 1.61757883 |
| 24 | JAK3 | 1.57878966 |
| 25 | IKBKB | 1.56646983 |
| 26 | CSK | 1.49151884 |
| 27 | DYRK3 | 1.44740205 |
| 28 | IKBKE | 1.42447646 |
| 29 | MAPK15 | 1.42050791 |
| 30 | ZAP70 | 1.38511907 |
| 31 | DAPK3 | 1.27892828 |
| 32 | MAP3K5 | 1.26507506 |
| 33 | RPS6KA5 | 1.24988874 |
| 34 | FES | 1.23137714 |
| 35 | PIM2 | 1.21061076 |
| 36 | MAP3K3 | 1.19100693 |
| 37 | LYN | 1.18712051 |
| 38 | DYRK1B | 1.17873628 |
| 39 | MAP4K2 | 1.17460466 |
| 40 | SYK | 1.14926870 |
| 41 | MAP3K4 | 1.13676542 |
| 42 | MAP3K14 | 1.13529990 |
| 43 | BMPR2 | 1.13199291 |
| 44 | PTK2B | 1.12624137 |
| 45 | CHUK | 1.09863521 |
| 46 | CSF1R | 1.04947530 |
| 47 | DAPK1 | 1.02648734 |
| 48 | MOS | 1.02111306 |
| 49 | MAP3K11 | 1.01628820 |
| 50 | TNK2 | 0.95679242 |
| 51 | IRAK3 | 0.95221942 |
| 52 | LIMK1 | 0.93907329 |
| 53 | SIK1 | 0.91470782 |
| 54 | MAP3K13 | 0.90812679 |
| 55 | MAP3K10 | 0.90269619 |
| 56 | MAPKAPK3 | 0.87917801 |
| 57 | TAOK3 | 0.85416319 |
| 58 | ADRBK2 | 0.85066037 |
| 59 | CSNK1G3 | 0.82449928 |
| 60 | BTK | 0.80696548 |
| 61 | RPS6KA4 | 0.79949609 |
| 62 | KIT | 0.78640197 |
| 63 | LMTK2 | 0.75672910 |
| 64 | PIM1 | 0.75307198 |
| 65 | PAK1 | 0.71642696 |
| 66 | RAF1 | 0.71355662 |
| 67 | MAP2K4 | 0.68781214 |
| 68 | SIK2 | 0.63483582 |
| 69 | CSNK1G2 | 0.63448556 |
| 70 | HCK | 0.62480001 |
| 71 | LCK | 0.60786688 |
| 72 | AURKA | 0.60378336 |
| 73 | TRIM28 | 0.58362846 |
| 74 | EPHB1 | 0.55621368 |
| 75 | CSNK1A1L | 0.54423812 |
| 76 | PIK3CG | 0.53197978 |
| 77 | GRK7 | 0.52173120 |
| 78 | TAF1 | 0.51920245 |
| 79 | ILK | 0.51289581 |
| 80 | DYRK2 | 0.50760643 |
| 81 | FYN | 0.50157198 |
| 82 | JAK1 | 0.46869607 |
| 83 | MST4 | 0.44216730 |
| 84 | MUSK | 0.44137827 |
| 85 | MAP3K6 | 0.43308931 |
| 86 | PAK4 | 0.41978701 |
| 87 | FGR | 0.41723208 |
| 88 | PRKCD | 0.39852079 |
| 89 | CDK14 | 0.39341688 |
| 90 | STK4 | 0.38699246 |
| 91 | HIPK2 | 0.34698293 |
| 92 | CDK15 | 0.33717478 |
| 93 | CDK18 | 0.33231572 |
| 94 | TXK | 0.32047367 |
| 95 | MAPK7 | 0.31802208 |
| 96 | CSNK1G1 | 0.30678646 |
| 97 | ITK | 0.30549050 |
| 98 | CDK11A | 0.29493959 |
| 99 | IRAK2 | 0.27871738 |
| 100 | JAK2 | 0.27840279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.43952312 |
| 2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.37494111 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.23324045 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.12166805 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.06687465 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.96199985 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.96160997 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.82502126 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64499038 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.51972319 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.40919516 |
| 12 | Shigellosis_Homo sapiens_hsa05131 | 2.12778010 |
| 13 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.12021130 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 2.10114211 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.08071418 |
| 16 | Alcoholism_Homo sapiens_hsa05034 | 2.01384967 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95280020 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.74297964 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73933607 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.73352646 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72693289 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.68871235 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66939245 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.55561899 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54838015 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50328569 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.47883010 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45199713 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38045698 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.35448792 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30374550 |
| 32 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.28884984 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24475394 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24360070 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.23861873 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.22512553 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20799593 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16895417 |
| 39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14696171 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.14477688 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14155305 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.09218170 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08046221 |
| 44 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.07800129 |
| 45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06682644 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06552248 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03082910 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.01799577 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.99042619 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.98959260 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93998135 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90421372 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89982418 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.89895802 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84719566 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84538648 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79493763 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79100248 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78008402 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.76927447 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76793574 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.69118289 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.66099374 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63980408 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.62524468 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62459724 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61563659 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.60533121 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.58917944 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 0.56503203 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56220113 |
| 72 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.55966241 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54825569 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53911530 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52923357 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51375067 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46064605 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45505041 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43146492 |
| 80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42498784 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40428315 |
| 82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40123615 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.38421419 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36629736 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36403551 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32951987 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.32675510 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32671647 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29697264 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.29449116 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29262852 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.26511147 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25237566 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.20641597 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20470619 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19028934 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.18445624 |
| 98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.17937918 |
| 99 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.17009386 |
| 100 | Spliceosome_Homo sapiens_hsa03040 | 0.15133883 |

